P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS

• Carolien Maas,
• David van Klaveren,
• Mujde Durmaz,
• Otto Visser,
• Djamila Issa,
• Eduardus F.M. Posthuma,
• Josée Zijlstra,
• Martine Chamuleau,
• Pieternella Lugtenburg,
• Marie José Kersten,
• Avinash Dinmohamed

Affiliations

Carolien Maas

1 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands

David van Klaveren

1 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands

Mujde Durmaz

2 Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, Utrecht, The Netherlands

Otto Visser

3 Netherlands Comprehensive Cancer Organisation (IKNL), Department of Registration, Utrecht, The Netherlands

Djamila Issa

4 Jeroen Bosch Hospital, Department of Internal Medicine, Den Bosch, The Netherlands

Eduardus F.M. Posthuma

5 Reinier de Graaf Gasthuis, Department of Internal Medicine, Delft, The Netherlands

Josée Zijlstra

7 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands

Martine Chamuleau

7 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands

Pieternella Lugtenburg

8 Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands

Marie José Kersten

7 Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands

Avinash Dinmohamed

1 Erasmus University Medical Centre, Department of Public Health, Rotterdam, The Netherlands